immunosuppressant peptides (Neurocrine)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameimmunosuppressant peptides (Neurocrine)
Drug Alias NameNBI-115NBI-114
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A